News
HC Wainwright & Co. Reiterates Buy on Galectin Therapeutics, Maintains $11 Price Target
9 Apr 24
News, Price Target, Reiteration, Analyst Ratings
Galectin Therapeutics Highlights Outcome Of Fifth Data and Safety Monitoring Board Meeting for NAVIGATE Phase 2b/3 Study
9 Apr 24
News, FDA
12 Health Care Stocks Moving In Friday's Intraday Session
5 Apr 24
Movers
HC Wainwright & Co. Reiterates Buy on Galectin Therapeutics, Maintains $11 Price Target
1 Apr 24
News, Price Target, Reiteration, Analyst Ratings